Radiosynthesis and evaluation of ytterbium-175 labeled bleomycin as therepeutic agent

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 265

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IRJNM-22-2_001

تاریخ نمایه سازی: 21 بهمن 1398

Abstract:

Introduction: Bleomycins are DNA-binding biomolecules, which can be used as targeted therapy carriers when labeled with particle-emitters such as Yb-175. In this work the development of Yb-175 bleomycin (175Yb-BLM) has been reported. Methods: Yb-175 chloride was obtained by thermal neutron irradiation (3 × 1013 n.cm-2.s-1) of natural Yb2O3 samples at various neutron fluxes and irradiation times. The radionuclide dissolved in acidic media (120mCi/mg) was used in the bleomycin (5 mg) labeling in buffer solution and warming at 60ºC for 48 h. Radiochemical purity was determined by ITLC as well as specific activity calculation followed by stability studies. Biodistribution studies of free Yb-175 and 175Yb-BLM were performed in wild-type mice up to 8 days. Results: At optimized conditions radiochemical purity of 97±0.88 % and specific activity of 1360 MBq/mM was obtained. Biodistribution studies of free Yb-175 demonstrated liver and bone uptake while in case of 175Yb-BLM the target tissues were lung, liver and spleen. Conclusion: 175Yb-BLM complex was prepared at the optimized conditions and suitable characteristics. The accumulation of the radiolabeled compound in lungs, liver and spleen demonstrates a similar pattern to the other radiolabeled bleomycins. Further studies are to be performed for application of this labeled compound in tumor-bearing models.

Authors

Ayuob Aghanejad

Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Amir Reza Jalilian

Nuclear Science Research School, Nuclear Science and Technology Research Institute, Tehran, Iran AND Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Tehran, Iran

Ali Bahrami-Samani

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Tehran, Iran

Simindokht Shirvani-Arani

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Korppi-Tommola T, Huhmar H, Aronen HJ, Penttilä P, Hiltunen J, ...
  • Zolghadri S, Jalilian AR, Yousefnia H, Bahrami-Samani A, Shirvani-Arani S, ...
  • Stern PH, Helpern SE, Hagan PL, Howell SB, Dabbs JE, ...
  • Yousefnia H, Jalilian AR, Zolghadri S, Bahrami-Samani A, Shirvani-Arani S, ...
  • Brooks RC, Carnochan P, Vollano JF, Powell NA, Zweit J, ...
  • Mathew B, Chakraborty S, Das T, Sarma HD, Banerjee S, ...
  • Chakraborty S, Das T, Banerjee S, Subramanian S, Sarma HD, ...
  • Firestone RB, Chu SYF, Baglin CM. Table of isotopes.  8th ...
  • Chakraborty S, Unni PR, Venkatesh M, Pillai MR. Feasibility study ...
  • Bahrami-Samani A, Anvari A, Jalilian AR, Shirvani-Arani S, Yousefnia H, ...
  • Takita T, Metal complex of bleomycin and its implication for ...
  • Moghaddam-Banaem L, Jalilian AR, Pourjavid M, Bahrami-Samani A, Mazidi M, ...
  • Jalilian AR, Rowshanfarzad P, Sabet M, Novinrooz A, Raisali G. ...
  • Melnyk DL, Horwitz SB, Peisach T. The oxidation-reduction potential of ...
  • Antholine WE, Solaiman D, Saryan LA, Petering DH. Studies on ...
  • Eckelman WC, Rzeszotarski WJ, Siegel BA, Kubota H, Chelliah M. ...
  • نمایش کامل مراجع